Stalevo Film Coated Tablets 150/37.5/200 mg
Product details
Registration number: SIN13141P
Classification: Prescription Only
Active ingredients:
- CARBIDOPA MONOHYDRATE EQV CARBIDOPA
- Entacapone
- Levodopa
Strength:
- 37.5 mg
- 200 mg
- 150 mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: ORION PHARMA (SG) PTE. LTD.
ATC code: Not recorded in this imported record.
HSA approval date: 29 August 2005
Manufacturer(s): Orion Corporation, Orion Pharma (Espoo site)
Manufacturing country/countries: FINLAND
What are the HSA registration number and classification for Stalevo Film Coated Tablets 150/37.5/200 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13141P
Classification: Prescription Only
What active ingredients and strength are recorded for Stalevo Film Coated Tablets 150/37.5/200 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CARBIDOPA MONOHYDRATE EQV CARBIDOPA
- Entacapone
- Levodopa
Strength:
- 37.5 mg
- 200 mg
- 150 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Stalevo Film Coated Tablets 150/37.5/200 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Stalevo Film Coated Tablets 150/37.5/200 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ORION PHARMA (SG) PTE. LTD.
Which manufacturers and countries are listed for Stalevo Film Coated Tablets 150/37.5/200 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Orion Corporation, Orion Pharma (Espoo site)
Manufacturing country/countries: FINLAND
Where can I look up Stalevo Film Coated Tablets 150/37.5/200 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13141P or the exact product name Stalevo Film Coated Tablets 150/37.5/200 mg. The general register link does not preselect this product.
What are the source dates for this Stalevo Film Coated Tablets 150/37.5/200 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Stalevo Film Coated Tablets 150/37.5/200 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13141P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)